title: Aortic root dilatation in young patients with cryptogenic stroke and patent foramen ovale.
abstract: BACKGROUND
  No previous study has looked for an association between aortic dilatation and the clinical sequelae of patent foramen ovale (PFO), although a possible relationship has been identified in case reports.
  
  
  OBJECTIVE
  To compare aortic dimensions in patients with symptomatic PFO and healthy controls.
  
  
  METHODS
  Forty-seven patients were identified who presented with cryptogenic cerebrovascular accident (CVA) assessed as most likely secondary to PFO (confirmed by contrast study), were aged less than 50 years and underwent percutaneous PFO closure. Forty-seven age-, sex- and body surface area-matched healthy controls were also identified.
  
  
  RESULTS
  Aortic root diameters were greater in PFO patients. The difference was more marked at the levels of the sinuses of Valsalva (34±4 vs 31±3 mm, P<0.01) and the proximal ascending aorta (32±4 vs 29±3, P<0.01) and more modest at the level of the aortic annulus (23±3 vs 22±2 mm, P=0.20). In addition, patients with massive right-to-left shunting tended to have larger aortic diameters. In contrast, left ventricular end-systolic and end-diastolic diameters were not larger than in controls (30±4 vs 32±5 mm, P=0.10 and 48±5 vs 50±4 mm, P=0.04, respectively).
  
  
  CONCLUSIONS
  The present study shows that aortic diameter is increased in young patients with cryptogenic CVA and PFO compared with in healthy subjects. Our results suggest that aortic dilatation may potentiate the risk of CVA in PFO patients and support further research in this area.
authors.affiliation: Cardiology Department, AP-HP, Bichat Hospital, Inserm U698, university Paris 7, 46, rue Henri-Huchard, 75018 Paris, France.
authors.forename: Niall G
authors.initials: NG
authors.lastname: Keenan
authors.forename: Éric
authors.initials: É
authors.lastname: Brochet
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Juliard
authors.forename: Mihaela
authors.initials: M
authors.lastname: Malanca
authors.forename: Pierre
authors.initials: P
authors.lastname: Aubry
authors.forename: Laurent
authors.initials: L
authors.lastname: Lepage
authors.forename: Caroline
authors.initials: C
authors.lastname: Cueff
authors.forename: Guillaume
authors.initials: G
authors.lastname: Jondeau
authors.forename: Bernard
authors.initials: B
authors.lastname: Iung
authors.forename: Alec
authors.initials: A
authors.lastname: Vahanian
authors.forename: David
authors.initials: D
authors.lastname: Messika-Zeitoun
mesh_terms: D000328:Adult; D001013:Aorta, Thoracic; D002404:Catheterization / Q000379:methods*; D017548:Echocardiography, Transesophageal; D005260:Female; D005500:Follow-Up Studies; D054092:Foramen Ovale, Patent / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy*; D006801:Humans; D008297:Male; D011379:Prognosis; D012189:Retrospective Studies; D020521:Stroke / Q000175:diagnosis / Q000209:etiology*; D016896:Treatment Outcome